TAG:
cap
Dr Lal PathLabs, Malpractice Costs, Med Tech Strike in New Zealand
By Robert Michel | From the Volume XVII No. 13 – September 13, 2010 Issue
BOSTON INVESTORS PURCHASE INTEREST IN DR LAL PATHLABS PATHOLOGY AND CLINICAL LABORATORY COMPANIES IN INDIA continue to attract investor interest. Last month, TA Associates, a private equity firm in Boston, Massachusetts, announced that it had purchased a minority interest in…
Epic Launches LIS Software To Fill Out Ancillary Offerings
By Robert Michel | From the Volume XVII No. 13 – September 13, 2010 Issue
MANY PATHOLOGISTS and laboratory administrators may be unaware that a company called Epic Systems Corporation is considered by some experts in healthcare informatics to be a disrupter of the status quo. Based in Verona, Wisconsin, Epic is best known for its acute an…
Payers Move to Pre-Authorize Expensive Genetic Tests
By Robert Michel | From the Volume XVII No. 13 – September 13, 2010 Issue
CEO Summary: Pre-authorization of expensive genetic and molecular tests is fast-becoming a priority for most of the nation’s health insurers. For clinical labs and pathology groups that don’t respond, this trend is a threat. On the other hand, because payers need all the skil…
More Hospitals Now Use Point-of-Care Test Devices
By Robert Michel | From the Volume XVII No. 12 – August 23, 2010 Issue
CEO SUMMARY: Point-of-care testing (POCT) continues to gain acceptance in hospitals across the nation. One factor in this trend is improved technology for both the POC assays and the POC systems, each of which contributes to a more accurate and reproducible POC test result. But a…
HIEs Boost Fortunes of Community Hospital Labs
By Robert Michel | From the Volume XVII No. 12 – August 23, 2010 Issue
CEO SUMMARY: Regional health information exchanges (HIEs) are becoming more common. In Southern Indiana, the HealthLINC HIE is boosting the value that the community hospital laboratory provides to physicians. At the top of the list is expedited turnaround of laboratory test resul…
Lab Manager Training Program Coming to Four Cities This Fall
By Robert Michel | From the Volume XVII No. 12 – August 23, 2010 Issue
WHEN IT COMES TO PREPARING the next generation of laboratory managers to assume leadership roles, pathologists and lab administrators have few options. That is about to change. This fall, in four different cities, workshops will be conducted specifically to provide your laboratory’s most promising…
Labs Hope to Renegotiate 1.75% Medicare Fee Cuts
By Robert Michel | From the Volume XVII No. 12 – August 23, 2010 Issue
CEO SUMMARY: As Congress crafted its reform of the nation’s healthcare system last year, it asked healthcare providers to contribute substantially to the cost of the Patient Protection and Affordable Care Act. The lab industry will see a 1.75% cut in reimbursement for Medicare …
Tough Financial Times Ahead for Hospital Labs
By R. Lewis Dark | From the Volume XVII No. 12 – August 23, 2010 Issue
THIS YEAR’S MASSIVE HEALTH REFORM LEGISLATION has a ticking financial time bomb for hospital laboratories. Starting October 1, Medicare Part A hospital fees will be reduced by 0.4% for the federal fiscal year 2011. This is expected to reduce Medicare Part A spending by $440 million in 2011 compared…
New “Meaningful Use” Rules Are Easier on Docs
By Robert Michel | From the Volume XVII No. 11 – August 2, 2010 Issue
CEO SUMMARY: The federal government will spend $20 billion over the next four years to encourage every physician to use an electronic medical record (EMR) system. For labs, this increase in connectivity represents a significant marketing opportunity. However, the new federal rule…
AAB’s Suit Prevails over NY State Following 11 Years of Litigation
By Robert Michel | From the Volume XVII No. 11 – August 2, 2010 Issue
SCORE A BIG WIN FOR THE GOOD GUYS! An appeals court in New York state has upheld a lower court ruling that the New York State Department of Health (NYSDOH) intentionally overcharged clinical laboratories for the costs of regulating clinical laboratories and blood banks, possibly goin…
CURRENT ISSUE

Volume XXXII, No. 12 – August 25, 2025
In an exclusive interview, a laboratory industry M&A specialist discusses what’s driving lab outreach sales to national lab companies. Also, The Dark Report analyzes ways in which pathology and clinical labs can profitably partner with pharmaceutical companies.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized